Search Results | Diabetes Care | American Diabetes Association

1-20 of 182

2 3 4 5

Sort by

Sort Order Select

Journal Articles

Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes

Kamlesh Khunti, Vanita R. Aroda

Diabetes Care 2022;45(4):766–768

DOI: https://doi.org/10.2337/dci21-0064

Published: 29 March 2022

View article

Journal Articles

GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease

Yi-Sun Yang, Hsin-Hung Chen, Chien-Ning Huang, Chung Y. Hsu, Kai-Chieh Hu, Chia-Hung Kao

Diabetes Care 2022;45(5):1184–1192

DOI: https://doi.org/10.2337/dc21-1993

Published: 11 March 2022

View article

Journal Articles

Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes

Evangelos K. Oikonomou, Marc A. Suchard, Darren K. McGuire, Rohan Khera

Diabetes Care 2022;45(4):965–974

DOI: https://doi.org/10.2337/dc21-1765

Published: 04 February 2022

View article

Journal Articles

Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes

Hui Shao, Piaopiao Li, Jingchuan Guo, Vivian Fonseca, Lizheng Shi, Ping Zhang

Diabetes Care 2022;45(2):e32–e33

DOI: https://doi.org/10.2337/dc21-1800

Published: 17 January 2022

View article

Journal Articles

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Dhruv Mahtta, David J. Ramsey, Michelle T. Lee, Liang Chen, Mahmoud Al Rifai, Julia M. Akeroyd, Elizabeth M. Vaughan, Michael E. Matheny, Karla Rodrigues do Espirito Santo, Sankar D. Navaneethan, Carl J. Lavie, Yochai Birnbaum, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani

Diabetes Care 2022;45(2):372–380

DOI: https://doi.org/10.2337/dc21-1815

Published: 17 January 2022

View article

Journal Articles

Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013–2018

Mohamad B. Taha, Javier Valero-Elizondo, Tamer Yahya, César Caraballo, Rohan Khera, Kershaw V. Patel, Hyeon Ju R. Ali, Garima Sharma, Elias Mossialos, Miguel Cainzos-Achirica, Khurram Nasir

Diabetes Care 2022;45(3):594–603

DOI: https://doi.org/10.2337/dc21-1757

Published: 11 January 2022

View article

Journal Articles

Association of Baseline HbA_1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

Avivit Cahn, Stephen D. Wiviott, Ofri Mosenzon, Erica L. Goodrich, Sabina A. Murphy, Ilan Yanuv, Aliza Rozenberg, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Anna Maria Langkilde, Marc S. Sabatine, Itamar Raz

Diabetes Care 2022;45(4):938–946

DOI: https://doi.org/10.2337/dc21-1744

Published: 11 January 2022

View article

Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

American Diabetes Association Professional Practice Committee

Diabetes Care 2022;45(Supplement_1):S144–S174

DOI: https://doi.org/10.2337/dc22-S010

Published: 16 December 2021

View article

Journal Articles

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

Abhinav Sharma, Yinggan Zheng, Justin A. Ezekowitz, Cynthia M. Westerhout, Jacob A. Udell, Shaun G. Goodman, Paul W. Armstrong, John B. Buse, Jennifer B. Green, Robert G. Josse, Keith D. Kaufman, Darren K. McGuire, Giuseppe Ambrosio, Lee-Ming Chuang, Renato D. Lopes, Eric D. Peterson, Rury R. Holman

Diabetes Care 2022;45(1):204–212

DOI: https://doi.org/10.2337/dc20-2806

Published: 29 October 2021

View article

Journal Articles

Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women

Yilin Yoshida, Zhipeng Chen, Robin L. Baudier, Marie Krousel-Wood, Amanda H. Anderson, Vivian A. Fonseca, Franck Mauvais-Jarvis

Diabetes Care 2021;44(11):2564–2572

DOI: https://doi.org/10.2337/dc21-1107

Published: 02 September 2021

View article

Journal Articles

Long-term Predictions of Incident Coronary Artery Calcium to 85 Years of Age for Asymptomatic Individuals With and Without Type 2 Diabetes

Bart S. Ferket, M.G. Myriam Hunink, Umesh Masharani, Wendy Max, Joseph Yeboah, Kirsten E. Fleischmann

Diabetes Care 2021;44(7):1664–1671

DOI: https://doi.org/10.2337/dc20-1960

Published: 20 July 2021

View article

Journal Articles

Application of 2021 American Diabetes Association Glycemic Treatment Clinical Practice Recommendations in Primary Care

Caitlin Colling, Steven J. Atlas, Deborah J. Wexler

Diabetes Care 2021;44(6):1443–1446

DOI: https://doi.org/10.2337/dc21-0013

Published: 18 June 2021

View article

Journal Articles

Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

Avivit Cahn, Itamar Raz, Lawrence A. Leiter, Ofri Mosenzon, Sabina A. Murphy, Erica L. Goodrich, Ilan Yanuv, Aliza Rozenberg, Deepak L. Bhatt, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Anna Maria Langkilde, Marc S. Sabatine, Stephen D. Wiviott

Diabetes Care 2021;44(5):1159–1167

DOI: https://doi.org/10.2337/dc20-2492

Published: 02 March 2021

View article

Journal Articles

The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study

Juraj Koska, Raymond Q. Migrino, Keith C. Chan, Kelly Cooper-Cox, Peter D. Reaven

Diabetes Care 2021;44(6):1385–1392

DOI: https://doi.org/10.2337/dc20-2014

Published: 25 January 2021

View article

Journal Articles

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes

Jamal S. Rana, Howard H. Moffet, Jennifer Y. Liu, Andrew J. Karter

Diabetes Care 2021;44(3):e40–e41

DOI: https://doi.org/10.2337/dc20-2798

Published: 20 January 2021

View article

Journal Articles

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

American Diabetes Association

Diabetes Care 2021;44(Supplement_1):S125–S150

DOI: https://doi.org/10.2337/dc21-S010

Published: 04 December 2020

View article

Journal Articles

Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness

Amra Jujić, Peter M. Nilsson, Naeimeh Atabaki-Pasdar, Anna Dieden, Tiinamaija Tuomi, Paul W. Franks, Jens Juul Holst, Signe Sørensen Torekov, Susana Ravassa, Javier Díez, Margaretha Persson, Emma Ahlqvist, Olle Melander, Maria F. Gomez, Leif Groop, Martin Magnusson

Diabetes Care 2021;44(1):224–230

DOI: https://doi.org/10.2337/dc20-1318

Published: 18 November 2020

View article

Journal Articles

Association of Cardiometabolic Multimorbidity and Depression With Cardiovascular Events in Early-Onset Adult Type 2 Diabetes: A Multiethnic Study in the U.S.

John Epoh Dibato, Olga Montvida, Francesco Zaccardi, Jack Alistair Sargeant, Melanie J. Davies, Kamlesh Khunti, Sanjoy K. Paul

Diabetes Care 2021;44(1):231–239

DOI: https://doi.org/10.2337/dc20-2045

Published: 11 November 2020

View article

Journal Articles

The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes

Ronald B. Goldberg, Neil J. Stone, Scott M. Grundy

Diabetes Care 2020;43(8):1673–1678

DOI: https://doi.org/10.2337/dci19-0036

Published: 10 July 2020

View article

Journal Articles

Predicting and Preventing Myocardial Infarction in the Young

Sandeep R. Das

Diabetes Care 2020;43(8):1679–1680

DOI: https://doi.org/10.2337/dci19-0051

Published: 10 July 2020

View article

2 3 4 5

NARROW

Coming Full Circle: Prioritizing Early Glycemic Control to Reduce Microvascular and Macrovascular Complications in People With Type 2 Diabetes

GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease

Phenomapping-Derived Tool to Individualize the Effect of Canagliflozin on Cardiovascular Risk in Type 2 Diabetes

Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Cost-Related Medication Nonadherence in Adults With Diabetes in the United States: The National Health Interview Survey 2013–2018

Association of Baseline HbA_1c With Cardiovascular and Renal Outcomes: Analyses From DECLARE-TIMI 58

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2022

Cluster Analysis of Cardiovascular Phenotypes in Patients With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease: A Potential Approach to Precision Medicine

Early Menopause and Cardiovascular Disease Risk in Women With or Without Type 2 Diabetes: A Pooled Analysis of 9,374 Postmenopausal Women

Long-term Predictions of Incident Coronary Artery Calcium to 85 Years of Age for Asymptomatic Individuals With and Without Type 2 Diabetes

Application of 2021 American Diabetes Association Glycemic Treatment Clinical Practice Recommendations in Primary Care

Cardiovascular, Renal, and Metabolic Outcomes of Dapagliflozin Versus Placebo in a Primary Cardiovascular Prevention Cohort: Analyses From DECLARE-TIMI 58

The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study

Severe Hypoglycemia and Risk of Atherosclerotic Cardiovascular Disease in Patients With Diabetes

10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2021

Glucose-Dependent Insulinotropic Peptide in the High-Normal Range Is Associated With Increased Carotid Intima-Media Thickness

Association of Cardiometabolic Multimorbidity and Depression With Cardiovascular Events in Early-Onset Adult Type 2 Diabetes: A Multiethnic Study in the U.S.

The 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guidelines on the Management of Blood Cholesterol in Diabetes

Predicting and Preventing Myocardial Infarction in the Young

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only